A historic legacy now translates to pioneering capabilities in electric grid technology at the Department of Energy's Oak ...

Familiar rivals clash again, but injuries and evolving offenses mean this playoff showdown is anything but predictable. Who ...

The regular season still has one more week to go, but the Green Bay Packers know their playoff fate. Head coach Matt LaFleur’s club has secured a playoff berth, but if Green Bay is going to make a ...

Pour one out for the ancient MetroCard and its equally old cousin, the PATH SmartLink card. The beginning of the end for these longtime ways to pay fares on the bi-state PATH system came Thursday when ...

Several states will start incorporating artificial intelligence into their Medicare coverage decisions starting January 1, but some experts are unimpressed, with one telling Newsweek, "If you show me ...

Abstract: A target path of Message Passing Interface (MPI) programs typically consists of several target sub-paths. During solving a test case that cover the target path using an intelligent ...

After an unforgettable end to the 2025 season, the Circuit Ricardo Tormo plays host to a crucial one-day Valencia Test. It’s the first opportunity for the riders to try some fresh parts and our first ...

Pennsylvania lawmakers are pushing to expand insurance coverage for Lyme disease testing as the state grapples with one of the highest rates of the disease in the country. The initiative, led by a ...

A subsurface atomic test near Yucca Flats, Nev., in March 1955. (U.S. Atomic Energy Commission via AP) In what would be a major shift in a decades-old American policy against global nuclear ...

The road to the second flight of Blue Origin’s heavy-lifting New Glenn rocket got a lot clearer Thursday night with a success test-firing of the launcher’s seven main engines on a launch pad at Cape ...

BridgeBio has vaulted over the success bar it set for a phase 3 rare disease trial, linking the candidate to significant improvements on biomarker and clinical outcomes to tee up a filing for FDA ...